May 25, 2016 1:23 PM ET

Pharmaceuticals

Company Overview of Allergan, Inc.

Key Executives for Allergan, Inc.

NameBoard RelationshipsTitleAge
David E. I. Pyott 175 RelationshipsChairman and Chief Executive Officer62
James M. Hindman 4 RelationshipsChief Financial Officer and Executive Vice President of Finance & Business Development54
James F. Barlow No RelationshipsPrincipal Accounting Officer, Senior Vice President and Corporate Controller56
Arnold A. Pinkston 11 RelationshipsExecutive Vice President, General Counsel, and Assistant Secretary56
Scott M. Whitcup M.D.47 RelationshipsChief Scientific Officer and Executive Vice President of Research & Development56

Allergan, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David E. I. Pyott 175 RelationshipsAllergan, Inc.62
Michael R. Gallagher 18 RelationshipsAllergan plc69
Russell T. Ray 49 RelationshipsHLM Venture Partners67
Trevor Mervy Jones CBE, Ph.D., DSc FKC FPS FRSC Hon FRCP FBPharmcolS 60 RelationshipsArthurian Life Sciences Ltd72
Henri A. Termeer 286 RelationshipsSanofi Biosurgery Inc.69
View All Board Members

Allergan, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Russell T. Ray49 Relationships3 Executives
Compensation Committee Michael R. Gallagher18 Relationships4 Executives
Corporate Governance Committee Henri A. Termeer286 Relationships4 Executives
Finance Committee Russell T. Ray49 Relationships3 Executives
Management/Organization Development Committee Michael R. Gallagher18 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$1.4M
1.4M
387.3K
Bonus$444.1M
Not meaningful
Total Short Term Compensation$1.4M
1.4M
580.9K
Total Value of Options
15.3M
Compensation as of Fiscal Year
Allergan, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Bliss Gvs Pharma Limited Approves Final Dividend for Fiscal 2016; Announces Board Changes
May 25, 2016 3:25 AM ET
Biodel Inc. and Albireo Limited Announces Management Changes
May 25, 2016 12:04 AM ET
Shardul S. Shroff Resigns from the Board of Directors of Jubilant Life Sciences Ltd
May 24, 2016 12:34 PM ET
Amplyx Pharmaceuticals, Inc. Appoints Paul C. Grint to Board of Directors
May 24, 2016 12:00 PM ET
Eisai Inc. Appoints Maria Garrigan as Vice President, Global Regulatory Strategy for the Oncology Business Group
May 24, 2016 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Allergan, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.